ISRCTN08788893
Completed
Not Applicable
ursing intervention for older patients who are discharged home from Emergency Department: A randomised controlled trial
niversity Hospital of Amager (Denmark)0 sites300 target enrollmentFebruary 17, 2010
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity Hospital of Amager (Denmark)
- Enrollment
- 300
- Status
- Completed
- Last Updated
- 11 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Patients 70 years and older scoring more than 2 points (out of 6\) when screened with Identification of Seniors at Risk 1 (ISAR 1\) screening tool (McCusker 1998\)
- •2\. Discharged home from Medical Emergency Department and residents of Amager, Copenhagen
- •3\. Able to decide on informed consent
- •4\. Able to communicate in Danish
Exclusion Criteria
- •1\. Patients admitted to Medical Emergency Department from nursing home
- •2\. Patients already included who are readmitted
- •3\. Spouses to already included patients
- •4\. Patients who do not wish to participate
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Developing better care for the elderly patients with walking disability due to degenerative lumbar spine stenosisISRCTN35836727Record Provided by the NHSTCT Register - 2006 Update - Department of Health20
Not yet recruiting
Not Applicable
Prerehabilitation for elderly patients undergoing gastrointestinal surgerygastrointestinal cancerJPRN-UMIN000049621agasaki University35
Completed
Not Applicable
Tailored treatment in Older Patients TOP-1: Omission of radiotherapy in elderly patients with low risk breast cancerNL-OMON53002eids Universitair Medisch Centrum1,200
Active, not recruiting
Phase 4
Optimising prescription of treatment in older patients with mild hypertension (high blood pressure) at increased risk of serious adverse eventsHypertensionCirculatory SystemISRCTN18030225niversity of Oxford3,014
Active, not recruiting
Phase 1
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-BESaarland University388